# Adalimumab Biosimilar in Clinical Practice

> **NCT04808739** · — · COMPLETED · sponsor: **Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau** · enrollment: 604 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **BIOLOGICAL:** Adalimumab

## Key facts

- **NCT ID:** NCT04808739
- **Lead sponsor:** Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-01
- **Primary completion:** 2021-02-28
- **Final completion:** 2021-02-28
- **Target enrollment:** 604 (ACTUAL)
- **Last updated:** 2021-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04808739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04808739, "Adalimumab Biosimilar in Clinical Practice". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT04808739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*